Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-10-051022)

Filing Details

Accession Number:: 0001140361-10-051022
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-12-22 16:30:49
Reporting Period:: 2010-12-20

Filing Date:: 2010-12-22
Accepted Time:: 2010-12-22 16:30:49
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
884731	Ariad Pharmaceuticals Inc	ARIA	Biological Products, (No Disgnostic Substances) (2836)	223106987

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1242998	R Jay Lamarche	C/O Ariad Pharmaceuticals, Inc. 26 Landsdowne Street Cambridge MA 02139		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-12-20	24,000	$5.00	576,903	No	4	S	Direct
Common Stock	Disposition	2010-12-20	800	$5.01	576,103	No	4	S	Direct
Common Stock	Disposition	2010-12-20	200	$5.01	575,903	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	6,696	Indirect	Wife

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2010.